A Nonhemolytic Group B Streptococcus Strain Exhibits Hypervirulence

Group B streptococci (GBS) are Gram-positive bacteria that are a leading cause of neonatal infections. Most invasive isolates are β-hemolytic, and hemolytic activity is critical for GBS virulence. Although nonhemolytic GBS strains are occasionally isolated, they are often thought to be virulence attenuated. In this study, we show that a nonhemolytic GBS strain (GB37) isolated from a septic neonate exhibits hypervirulence. Substitution of tryptophan to leucine (W297L) in the sensor histidine kinase CovS results in constitutive kinase signaling, leading to decreased hemolysis and increased activity of the GBS hyaluronidase, HylB. These results describe how nonpigmented and nonhemolytic GBS strains can exhibit hypervirulence.

[1]  Lakshmi Rajagopal,et al.  Bacterial Hyaluronidase Promotes Ascending GBS Infection and Preterm Birth , 2016, mBio.

[2]  H. Davies,et al.  Draft Genome Sequence of an Invasive Streptococcus agalactiae Isolate Lacking Pigmentation , 2016, Genome Announcements.

[3]  V. Nizet,et al.  Group B Streptococcus Evades Host Immunity by Degrading Hyaluronan. , 2015, Cell host & microbe.

[4]  B. Spellerberg,et al.  Non-haemolytic and non-pigmented group b streptococcus, an infrequent cause of early onset neonatal sepsis. , 2015, Pathogens and disease.

[5]  A. Fouet,et al.  Molecular Characterization of Nonhemolytic and Nonpigmented Group B Streptococci Responsible for Human Invasive Infections , 2015, Journal of Clinical Microbiology.

[6]  Chengping Lu,et al.  Two Novel Functions of Hyaluronidase from Streptococcus agalactiae Are Enhanced Intracellular Survival and Inhibition of Proinflammatory Cytokine Expression , 2014, Infection and Immunity.

[7]  L. Aravind,et al.  A hemolytic pigment of Group B Streptococcus allows bacterial penetration of human placenta , 2013, The Journal of experimental medicine.

[8]  D. Golenbock,et al.  The Abi-domain Protein Abx1 Interacts with the CovS Histidine Kinase to Control Virulence Gene Expression in Group B Streptococcus , 2013, PLoS pathogens.

[9]  C. Renken,et al.  Regulation of CovR expression in Group B Streptococcus impacts blood–brain barrier penetration , 2010, Molecular microbiology.

[10]  V. Nizet,et al.  Bacterial Phenotype Variants in Group B Streptococcal Toxic Shock Syndrome , 2009, Emerging infectious diseases.

[11]  M. Vergassola,et al.  CovS/CovR of group B streptococcus: a two‐component global regulatory system involved in virulence , 2004, Molecular microbiology.

[12]  V. Nizet,et al.  Group B streptococcal beta-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis. , 2003, The Journal of clinical investigation.

[13]  H. Davies,et al.  Perinatal Antibiotic Usage and Changes in Colonization and Resistance Rates of Group B Streptococcus and Other Pathogens , 2002, Obstetrics and gynecology.

[14]  C. Adair,et al.  Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. , 2001, The Journal of infectious diseases.

[15]  D. Kasper,et al.  Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci , 1992, Infection and immunity.